Advertisement

Topics

Ligand to Receive $2 Million from WuXi Biologics for Licensing Clinical-Stage anti-PD-1 ...

04:06 EDT 18 Aug 2017 | BioMedReports - Blog

Ligand Pharmaceuticals Incorporated
Todd Pettingill
investors@ligand.com
(858) 550-7500
@Ligand_LGND
or
LHA
Bruce Voss
bvoss@lhai.com
(310) 691-7100

Read more...

Original Article: Ligand to Receive $2 Million from WuXi Biologics for Licensing Clinical-Stage anti-PD-1 ...

NEXT ARTICLE

More From BioPortfolio on "Ligand to Receive $2 Million from WuXi Biologics for Licensing Clinical-Stage anti-PD-1 ..."

Advertisement
Quick Search
Advertisement
Advertisement